Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-02-12

Clinical Trial Update: Effects of Dronedarone on Cardiac Geometry and Function in Patients With Atrial Fibrillation and Left Atrial Enlargement [Phase 4]

View source ↗

Summary

A Phase 4 study assessed the effects of dronedarone on cardiac geometry and function in patients with atrial fibrillation and left atrial enlargement; the trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dronedarone (dronedarone)

Snippet

Sponsor: Sanofi | Conditions: Atrial Fibrillation | Phase 4 | Status: TERMINATED | Results posted: 2013-02-12